Pain in connection with capillary blood test at different sites in the palm
DOI:
https://doi.org/10.1002/edn.22Keywords:
blood glucose self-monitoring, pain measurements, capillary blood test, test-sites, Pain-O-Meter®Abstract
AbstractThere are studies suggesting that fear of blood and injury is associated with less frequent self-testing; by reducing pain when measuring blood glucose the number of measurements can probably increase.
The aim of this study was to investigate whether or not there were any differences regarding pain at different test sites in the palm.
Twenty type 1 diabetes subjects pricked themselves at four different sites in the palm in the non-dominant hand in a randomised order with the Freestyle® punction device loaded with BD Microfine+ lancets. Pain was evaluated by the subjects using the Pain-O-Meter®.
The result (n=80) showed no statistically significant difference in pain score between the investigated sites.
The level of sensory pain was reported: shooting (n=36), no pain (n=27), searing (n=8), soaring (n=5), pressing (n=2), aching (n=1) and burning (n=1); 86% (n=69) of the pricked sites were experienced as no pain at all.
This study shows that pain in connection with capillary blood test is low as measured by the Pain-O-Meter. There are no significant differences in the pain experienced at different sites in the palm. More studies need to be done using different punction devices and more sites need to be investigated.
Downloads
References
Socialstyrelsen Nationella riktlinjer for yard vid diabetes mellitus. [Swedish Board of health care and welfare; National guidelines for care of diabetes mellitus]. Version for halso-ochsjukvardsperson al,LinkOping: Socialstyrelsen, 1999; 38–39.
Fruhstorfer H, Selzer K, Selbman O. Capillary blood sampling: how much pain is necessary? Pract Diabetes Int 1999; 13(2): 58–60.
Peled N, Wong D, Gwalani SL. Comparison of Glucose Levels in Capillary Blood Samples obtained from Variety of Body Sites. Diabetes Technol Ther 2002; 4(1): 35–44.
Fineberg SE, Bergenstal RM, Bernstein RM, et aL Use of an Automated Device for Alternative Site Blood Glucose Monitoring. Diabetes Care 2001; 24: 1217–1220.
Bennion N, Christensen NK, Kaufmann N, et aL. Blood glucose self-monitoring from abdominal skin: a precise and virtual pain-free method. Diabetes Technol Ther 2002; 4(1): 25–33.
Pfutzner A, Hermanns N, Schroder S, et aL. Cross-sectional investigation on the accuracy of alternative site glucose testing using the Soft-Sense glucose meter. Swiss Medicine Wkly 2002; 132: 351–357.
Jungheim K, Koschinsky T. Glucose Monitoring at Thenar: Evaluation of Upper Dermal Blood Glucose Kinetics Rapid Systemic Blood Glucose Changes. Horm Metab Res 2002; 34: 325–329.
Gaston-Johansson F. Measurement of pain: the psychometric properties of Pain-O-Meter, a simple inexpen-sive pain assessment tool that could change health care practices. J Pain Symptom Management 1996; 12(3): 172–181.
McGuire DB. Measuring pain. In Frank-Stromberg M, Olsen SJ (eds). Instruments for clinical health-care research, 2nd edn. London, UK Jones and Bartlett Publishers, Inc., 1997; 528–537.
Lee DM, Weinert SE, Miller EE. A study of forearm versus finger stick glucose monitoring. Diabetes Technol Ther 2002; 4(1): 13–23; discussion 45–47.
Gaston-Johansson F, Hofgren C, Watson P, et al. Myocardial infarction pain: systematic description and analysis. Intensive Care Nursing 1991; 7: 3–10.
Gaston-Johansson F, Franco-Crowley T, Zimmerman L. Pain and physio-logical distress in patients undergo-ing bone marrow transplantation. Oncology Nursing Forum 1992; 19: 41–48.
Ragnarsson Tennvall G. The Diabetic Foot, cost, health economic aspects, prevention and quality of life. Lund University, Department of Internal Medicine, Sweden, 2001.
Khalil OS. Spectroscopic and clinical aspects of non-invasive glucose meas-urements. Clinical Chemistry 1999; 45(2): 165–177.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2005 Copyright © 2005 FEND
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.